Effects of Aphasia Identification Cards on Service Workers' Comprehension of People With Aphasia
Launched by UNIVERSITY OF MASSACHUSETTS, AMHERST · May 21, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well healthy volunteers can understand people with aphasia, a condition that affects how a person speaks and understands language. Researchers want to find out if using an aphasia identification card—designed to help explain the communication difficulties of people with aphasia—can help volunteers better understand the language errors and long pauses in speech that often occur. By comparing the experiences of volunteers who view the ID card to those who do not, the study aims to see if the card makes a difference in comprehension.
To participate, you would need to be an adult between 18 and 59 years old, currently working as a service worker, and capable of understanding English well. You should have normal vision or be able to correct it with glasses or contacts. During a single visit that lasts about two hours, you would take some brief tests related to vision and thinking, listen to sentences from a speaker with aphasia while your eye movements are recorded, and fill out a survey about your experience. This study is not yet recruiting, but it's a valuable opportunity to help improve communication strategies for people with aphasia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult age 18-59
- • Currently employed as a service worker
- • Understand spoken and written English well
- • High school diploma or equivalency
- • Normal vision or corrected vision with glasses or contact lenses
- Exclusion Criteria:
- • Language disorder
- • Hearing impairment
- • Intellectual disability
- • History of acquired neurological disorder (e.g., stroke or moderate/severe brain injury)
About University Of Massachusetts, Amherst
The University of Massachusetts Amherst is a leading research institution dedicated to advancing knowledge and improving public health through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in biomedical research, social sciences, and engineering to address pressing health challenges. UMass Amherst is committed to conducting rigorous and ethical clinical studies that contribute to the development of effective therapies and interventions, ultimately enhancing patient care and community well-being. The university's state-of-the-art facilities and experienced research teams support a diverse portfolio of clinical trials, fostering an environment of discovery and excellence in medical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Springfield, Massachusetts, United States
Patients applied
Trial Officials
Jennifer Mack, PhD
Principal Investigator
University of Massachusetts, Amherst
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported